DGAP-News

Carl Zeiss Meditec AG: Carl Zeiss Meditec AG grows in Ophthalmology and Microsurgery - Seite 3

is rounded off by promising future technologies such as intra-operative
radiotherapy. With around 2,900 employees, the Group generated revenue of
EUR 1,040 million in fiscal year 2014/15 (30 September
).

The head office of the Carl Zeiss Meditec Group is in Jena, Germany. The
Company has subsidiaries in Germany and abroad; more than 50 percent of its
employees are based in the USA, Japan, Spain and France. The Center for
Application & Research India (CARIn) in Bangalore, India and the ZEISS
Innovations Center for Research and Development in Shanghai, China,
strengthen the Company's presence in these rapidly developing economies.
Around
35 percent of Carl Zeiss Meditec AG shares are in free float. The remaining
approx. 65 percent are held by Carl Zeiss AG, one of the world's leading
groups in the optical and optoelectronic industries.

For more information visit our website at: www.zeiss.de/med


---------------------------------------------------------------------------

12.08.2016 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail],[e-mail]
Internet: www.meditec.zeiss.de
ISIN: DE0005313704
WKN: 531370
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
Munich, Stuttgart, Tradegate Exchange


End of News DGAP News Service
---------------------------------------------------------------------------

491995 12.08.2016